Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Filed with BSE · · 2 pages · English
Subject: Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended on December 31, 2024 In accordance with Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018, for the Quarter ended on December 31, 2024, based on the certificate received from BEETAL FINANCIAL & COMPUTER SERVICES (P) LTD (RTA) dated 04/01/2025
Earlier from Titan Biotech
- Titan Biotech Limited Press Release Dec 31 2024
- Closure of Trading Window
- Titan Biotech Limited Press Release Dec 17 2024
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
- Titan Biotech Limited Press Release Dec 10 2024
Later from Titan Biotech
- Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Financial Results For Quarter Ending On 31St December, 2024
- Titan Biotech Limited Press Release Feb 03 2025
- Unaudited Financial Result For The Quarter And Nine Months Ended On 31St December, 2024
- Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Result
- Titan Biotech Limited Press Release Feb 12 2025
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech